The IL-20 subfamily of cytokines-from host defence to tissue homeostasis

Nature Reviews Immunology

Volumn 14, Issue 12, 2014, Pages 783-795

  Rutz, Sascha ^a   Wang, Xiaoting ^a   Ouyang, Wenjun ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 19; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 24; INTERLEUKIN 26; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-22;

ATHEROSCLEROSIS; BONE MARROW CELL; CELL PROTECTION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; ENTHESITIS; EPITHELIUM; EPITHELIUM CELL; HOMEOSTASIS; HOST RESISTANCE; HUMAN; INFECTION; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; LEUKOCYTE; LYMPHOID CELL; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE REGENERATION; TISSUE REPAIR; TISSUES; WOUND HEALING; ANIMAL; CELL COMMUNICATION; CHEMICAL STRUCTURE; CYTOLOGY; IMMUNOLOGY;

ANIMALS; CELL COMMUNICATION; EPITHELIAL CELLS; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKINS; LEUKOCYTES; MODELS, MOLECULAR; RECEPTORS, INTERLEUKIN;

EID: 84922479625     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3766     Document Type: Review

References (190)

1. Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., Hymowitz, S. G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29, 71-109 (2011).
2. Sabat, R., Ouyang, W., Wolk, K. Therapeutic opportunities of the IL-22-IL-22R1 system. Nature Rev. Drug Discov. 13, 21-38 (2014).
3. Leng, R.-X., Pan, H.-F., Tao, J.-H., Ye, D.-Q. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases. Expert Opin. Ther. Targets 15, 119-126 (2011).
4. Gallagher, G. et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun. 1, 442-450 (2000).
5. Blumberg, H. et al. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104, 9-19 (2001).
6. Dumoutier, L., Louahed, J., Renauld, J. C. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J. Immunol. 164, 1814-1819 (2000).
7. Jiang, H., Lin, J. J., Su, Z. Z., Goldstein, N. I., Fisher, P. B. Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression. Oncogene 11, 2477-2486 (1995).
8. Wang, T., Diaz-Rosales, P., Martin, S. A., Secombes, C. J. Cloning of a novel interleukin (IL)-20-like gene in rainbow trout Oncorhynchus mykiss gives an insight into the evolution of the IL-10 family. Dev. Comp. Immunol. 34, 158-167 (2010).
9. Knappe, A., Hor, S., Wittmann, S., Fickenscher, H. Induction of a novel cellular homolog of interleukin-10, AK155, by transformation of T lymphocytes with herpesvirus saimiri. J. Virol. 74, 3881-3887 (2000).
10. Jones, E. A., Flavell, R. A. Distal enhancer elements transcribe intergenic RNA in the IL-10 family gene cluster. J. Immunol. 175, 7437-7446 (2005).
11. Pestka, S. et al. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22, 929-979 (2004).
12. Aggarwal, S., Xie, M. H., Maruoka, M., Foster, J., Gurney, A. L. Acinar cells of the pancreas are a target of interleukin-22. J. Interferon Cytokine Res. 21, 1047-1053 (2001).
13. Kotenko, S. V. et al. Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J. Immunol. 166, 7096-7103 (2001).
14. Xu, W. et al. A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc. Natl Acad. Sci. USA 98, 9511-9516 (2001).
15. Martin, J. C. et al. Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid. Mucosal Immunol. 7, 101-113 (2014).
16. Huber, S. et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491, 259-263 (2012).
17. Weathington, N. M. et al. Glycogen synthase kinase-3 stabilizes the interleukin (IL)-22 receptor from proteasomal degradation in murine lung epithelia. J. Biol. Chem. 289, 17610-17619 (2014).
18. Wolk, K., Kunz, S., Asadullah, K., Sabat, R. Cutting edge: immune cells as sources and targets of the IL-10 family members? J. Immunol. 168, 5397-5402 (2002).
19. Zheng, Y. et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 (2007).
20. Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Med. 14, 282-289 (2008).
21. de Luca, A. et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 3, 361-373 (2010).
22. Pickert, G. et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 206, 1465-1472 (2009).
23. Zindl, C. L. et al. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc. Natl Acad. Sci. USA 110, 12768-12773 (2013).
24. Wang, F. et al. Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: Gene regulation and cellular effects. J. Investigative Dermatol. 126, 1590-1599 (2006).
25. Wolk, K. et al. Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes. J. Leukoc. Biol. 83, 1181-1193 (2008).
26. Sa, S. M. et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J. Immunol. 178, 2229-2240 (2007)
27. Yano, S., Banno, T., Walsh, R., Blumenberg, M. Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1. J. Cell. Physiol. 214, 1-13 (2008).
28. Hunt, D. W. et al. Ultraviolet B light stimulates interleukin-20 expression by human epithelial keratinocytes. Photochem. Photobiol. 82, 1292-1300 (2006).
29. Wolk, K. et al. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis. Eur. J. Immunol. 39, 3570-3581 (2009).
30. Aujla, S. J. et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nature Med. 14, 275-281 (2008).
31. Huang, F. et al. Potentiation of IL-19 expression in airway epithelia by IL-17A and IL-4/IL-13: important implications in asthma. J. Allergy Clin. Immunol. 121, 1415-1421 (2008).
32. Rutz, S., Eidenschenk, C., Ouyang, W. IL-22, not simply a Th17 cytokine. Immunol. Rev. 252, 116-132 (2013).
33. Ouyang, W., Kolls, J. K., Zheng, Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28, 454-467 (2008).
34. Colonna, M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31, 15-23 (2009).
35. Cupedo, T. et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nature Immunol. 10, 66-74 (2009).
36. Martin, B., Hirota, K., Cua, D. J., Stockinger, B., Veldhoen, M. Interleukin-17-producing T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321-330 (2009).
37. Sutton, C. E. et al. Interleukin-1 and IL-23 induce innate IL-17 production from T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331-341 (2009).
38. Takatori, H. et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206, 35-41 (2009).
39. Spits, H. et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nature Rev. Immunology 13, 145-149 (2013).
40. Satoh-Takayama, N. et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958-970 (2008).
41. Luci, C. et al. Influence of the transcription factor ROR?t on the development of NKp46+ cell populations in gut and skin. Nature Immunol. 10, 75-82 (2009).
42. Sanos, S. L. et al. ROR?t and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nature Immunol. 10, 83-91 (2009).
43. Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
44. Crellin, N. K., Trifari, S., Kaplan, C. D., Cupedo, T., Spits, H. Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells. J. Exp. Med. 207, 281-290 (2010).
45. Liang, S. C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006)
46. Chung, Y. et al. Expression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes. Cell Res. 16, 902-907 (2006).
47. Gurney, A. L. IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int. Immunopharmacol. 4, 669-677 (2004).
48. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A., Sallusto, F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nature Immunol. 10, 857-863 (2009).
49. Eyerich, S. et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 119, 3573-3585 (2009).
50. Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K., Spits, H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells. Nature Immunol. 10, 864-871 (2009).
51. Basu, R. et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 37, 1061-1075 (2012).
52. McGeachy, M. J. et al. TGF-? and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nature Immunol. 8, 1390-1397 (2007).
53. Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480-483 (2007).
54. Kreymborg, K. et al. IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but not required for the development of autoimmune encephalomyelitis. J. Immunol. 179, 8098-8104 (2007).
55. Siegemund, S. et al. Differential IL-23 requirement for IL-22 and IL-17A production during innate immunity against Salmonella enterica serovar Enteritidis. Int. Immunol. 21, 555-565 (2009).
56. Mus, A. M. C. et al. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis. Arthritis Rheum. 62, 1043-1050 (2010).
57. Mukherjee, S., Schaller, M. A., Neupane, R., Kunkel, S. L., Lukacs, N. W. Regulation of T cell activation by Notch ligand, DLL4, promotes IL-17 production and Rorc activation. J. Immunol. 182, 7381-7388 (2009).
58. Alam, M. S. et al. Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. USA 107, 5943-5948 (2010).
59. Veldhoen, M., Hirota, K., Christensen, J., O.&apos, Garra, A., Stockinger, B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 206, 43-49 (2009).
60. Veldhoen, M. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106-109 (2008).
61. Schaefer, G., Venkataraman, C., Schindler, U. Cutting edge: FISP (IL-4-induced secreted protein), a novel cytokine-like molecule secreted by Th2 cells. J. Immunol. 166, 5859-5863 (2001).
62. Stevens, L. et al. Involvement of GATA3 in protein kinase C ?-induced Th2 cytokine expression. Eur. J. Immunol. 36, 3305-3314 (2006).
63. Sahoo, A. et al. Stat6 and c-Jun mediate Th2 cell-specific IL-24 gene expression. J. Immunol. 186, 4098-4109 (2011).
64. Wilson, N. J. et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nature Immunol. 8, 950-957 (2007).
65. Manel, N., Unutmaz, D., Littman, D. R. The differentiation of human TH-17 cells requires transforming growth factor-? and induction of the nuclear receptor ROR?t. Nature Immunol. 9, 641-649 (2008).
66. Crellin, N. K. et al. Regulation of cytokine secretion in human CD127+ LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 33, 752-764 (2010).
67. Satpathy, A. T. et al. Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nature Immunol. 14, 937-948 (2013).
68. Van Maele, L. et al. TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3negCD127+ immune cells in spleen and mucosa. J. Immunol. 185, 1177-1185 (2010).
69. Bogunovic, M. et al. Origin of the lamina propria dendritic cell network. Immunity 31, 513-525 (2009).
70. Varol, C. et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31, 502-512 (2009).
71. Coombes, J. L., Maloy, K. J. Control of intestinal homeostasis by regulatory T cells and dendritic cells. Semin. Immunol. 19, 116-126 (2007).
72. Kinnebrew, M. A. et al. Interleukin 23 production by intestinal CD103+CD11b+ dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 36, 276-287 (2012).
73. Kinnebrew, M. A. et al. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J. Infect. Dis. 201, 534-543 (2010).
74. Ota, N. et al. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nature Immunol. 12, 941-948 (2011).
75. Tumanov, A. V. et al. Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host Microbe 10, 44-53 (2011).
76. Spahn, T. W. et al. The lymphotoxin-receptor is critical for control of murine Citrobacter rodentium-induced colitis. Gastroenterology 127, 1463-1473 (2004).
77. Wang, Y. et al. Lymphotoxin ? receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity 32, 403-413 (2010).
78. Manta, C. et al. CX3CR1+ macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol. 6, 177-188 (2013)
79. Sonnenberg, G. F., Monticelli, L. A., Elloso, M. M., Fouser, L. A., Artis, D. CD4+ lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34, 122-134 (2011).
80. Zigmond, E. et al. Ly6Chi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37, 1076-1090 (2012).
81. Kim, Y.-G. et al. The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity 34, 769-780 (2011).
82. Colonna, M. Skin function for human CD1a-reactive T cells. Nature Immunol. 11, 1079-1080 (2010).
83. de Jong, A. et al. CD1a-autoreactive T cells are a normal component of the human T cell repertoire. Nature Immunol. 11, 1102-1109 (2010).
84. Sonnenberg, G. F., Fouser, L. A., Artis, D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nature Immunol. 12, 383-390 (2011).
85. Hackstein, H. et al. Modulation of respiratory dendritic cells during Klebsiella pneumonia infection. Respir. Res. 14, 91 (2013).
86. Ermers, M. J. et al. IL10 family member genes IL19 and IL20 are associated with recurrent wheeze after respiratory syncytial virus bronchiolitis. Pediatr. Res. 70, 518-523 (2011).
87. Sonnenberg, G. F. et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336, 1321-1325 (2012).
88. Eidenschenk, C., Rutz, S., Liesenfeld, O., Ouyang, W. Role of IL-22 in microbial host defense. Curr. Top. Microbiol. Immunol. 380, 213-236 (2014).
89. Paget, C. et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages. J. Biol. Chem. 287, 8816-8829 (2012).
90. Wolk, K. et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 36, 1309-1323 (2006).
91. Boniface, K. et al. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 174, 3695-3702 (2005).
92. Dambacher, J. et al. The role of the novel Th17 cytokine IL-26 in intestinal inflammation. Gut 58, 1207-1217 (2009).
93. Behnsen, J. et al. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity 40, 262-273 (2014).
94. Liu, J. Z. et al. Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell Host Microbe 11, 227-239 (2012).
95. Raffatellu, M. et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 5, 476-486 (2009).
96. Stelter, C. et al. Salmonella-induced mucosal lectin RegIII kills competing gut microbiota. PLoS ONE 6, e20749 (2011).
97. Winter, S. E., Lopez, C. A., Baumler, A. J. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep. 14, 319-327 (2013).
98. Myles, I. A. et al. Signaling via the IL-20 receptor inhibits cutaneous production of IL-1? and IL-17A to promote infection with methicillin-resistant Staphylococcus aureus. Nature Immunol. 14, 804-811 (2013).
99. Miller, L. S. et al. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24, 79-91 (2006).
100. Cho, J. S. et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J. Clin. Invest. 120, 1762-1773 (2010).
101. Lowes, M. A., Bowcock, A. M., Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature 445, 866-873 (2007).
102. He, M., Liang, P. IL-24 transgenic mice: in vivo evidence of overlapping functions for IL-20, IL-22, and IL-24 in the epidermis. J. Immunol. 184, 1793-1798 (2010).
103. Wolk, K. et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN- are not. J. Mol. Med. 87, 523-536 (2009).
104. Wolk, K. et al. IL-22 increases the innate immunity of tissues. Immunity 21, 241-254 (2004)
105. Romer, J. et al. Epidermal overexpression of interleukin-19 and-20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol. J. Invest. Dermatol. 121, 1306-1311 (2003).
106. Otkjaer, K. et al. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br. J. Dermatol. 153, 911-918 (2005).
107. Ouyang, W. Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease. Cytokine Growth Factor Rev. 21, 435-441 (2010).
108. Brand, S. et al. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G827-G838 (2006).
109. Andoh, A. et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129, 969-984 (2005).
110. Sugimoto, K. et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118, 534-544 (2008).
111. Zenewicz, L. A. et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29, 947-957 (2008).
112. Neufert, C. et al. Activation of epithelial STAT3 regulates intestinal homeostasis. Cell Cycle 9, 652-655 (2010).
113. Fonseca-Camarillo, G., Furuzawa-Carballeda, J., Granados, J., Yamamoto-Furusho, J. K. Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study. Clin. Exp. Immunol. 177, 64-75 (2014).
114. Fonseca-Camarillo, G., Furuzawa-Carballeda, J., Llorente, L., Yamamoto-Furusho, J. K. IL-10-and IL-20-expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis. J. Clin. Immunol. 33, 640-648 (2013).
115. Andoh, A. et al. Expression of IL-24, an activator of the JAK1/STAT3/SOCS3 cascade, is enhanced in inflammatory bowel disease. J. Immunol. 183, 687-695 (2009).
116. Azuma, Y. T. et al. Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm. Bowel Dis. 16, 1017-1028 (2010).
117. Sakurai, N. et al. Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation. Rheumatol. 47, 815-820 (2008).
118. Ikeuchi, H. et al. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 52, 1037-1046 (2005).
119. Kragstrup, T. W. et al. The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine 41, 16-23 (2008).
120. Corvaisier, M. et al. IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation. PLoS Biol. 10, e1001395 (2012).
121. Alanara, T., Karstila, K., Moilanen, T., Silvennoinen, O., Isomaki, P. Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints. Scand. J. Rheumatol 39, 118-126 (2010).
122. Hsu, Y.-H. et al. Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. Arthritis Rheum. 54, 2722-2733 (2006).
123. P?ne, J. et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol. 180, 7423-7430 (2008).
124. Shen, H., Goodall, J. C., Hill Gaston, J. S. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 60, 1647-1656 (2009).
125. Leipe, J. et al. Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis. Ann. Rheum. Dis. 70, 1453-1457 (2011).
126. Zhang, L. et al. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS ONE 7, e31000 (2012).
127. Hsu, Y. H., Hsieh, P. P., Chang, M. S. Interleukin-19 blockade attenuates collagen-induced arthritis in rats. Rheumatol. 51, 434-442 (2012).
128. Zhang, L. et al. Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis. J. Clin. Immunol. 31, 606-614 (2011).
129. da Rocha, L. F. et al. Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity. J. Rheumatol. 39, 1320-1325 (2012).
130. Geboes, L. et al. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum. 60, 390-395 (2009).
131. Justa, S., Zhou, X., Sarkar, S. Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN- responses. PLoS ONE 9, e93279 (2014).
132. Marijnissen, R. J. et al. Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation. Arthritis Rheum. 63, 2939-2948 (2011).
133. Sherlock, J. P. et al. IL-23 induces spondyloarthropathy by acting on ROR-?t+ CD3+CD4-CD8-entheseal resident T cells. Nature Med. 18, 1069-1076 (2012).
134. Benham, H. et al. IL-23-mediates the intestinal response to microbial ?-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis Rheumatol. 66, 1755-1767 (2014).
135. Benham, H. et al. Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res. Ther. 15, R136 (2013).
136. Ortonne, J. P. Aetiology and pathogenesis of psoriasis. Br. J. Dermatol. 135 (Suppl. 49), 1-5 (1996).
137. Sano, S. et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nature Med. 11, 43-49 (2005).
138. Sun, D. P. et al. Interleukin (IL)-19 promoted skin wound healing by increasing fibroblast keratinocyte growth factor expression. Cytokine 62, 360-368 (2013).
139. McGee, H. M. et al. IL-22 promotes fibroblast-mediated wound repair in the skin. J. Invest. Dermatol. 133, 1321-1329 (2013)
140. Poindexter, N. J. et al. IL-24 is expressed during wound repair and inhibits TGF?-induced migration and proliferation of keratinocytes. Exp. Dermatol. 19, 714-722 (2010).
141. Bao, P. et al. The role of vascular endothelial growth factor in wound healing. J. Surg. Res. 153, 347-358 (2009).
142. Perera, G. K. et al. Integrative biology approach identifies cytokine targeting strategies for psoriasis. Sci. Transl. Med. 6, 223ra22 (2014).
143. Hanash, A. M. et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37, 339-350 (2012).
144. Radaeva, S., Sun, R., Pan, H. N., Hong, F., Gao, B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39, 1332-1342 (2004).
145. Zenewicz, L. A. et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27, 647-659 (2007).
146. Pan, H., Hong, F., Radaeva, S., Gao, B. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. Cell. Mol. Immunol. 1, 43-49 (2004).
147. Park, O. et al. In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 54, 252-261 (2011).
148. Ki, S. H. et al. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 52, 1291-1300 (2010).
149. Kong, X. et al. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 56, 1150-1159 (2012).
150. Ren, X., Colletti, L. M. IL-22 is involved in liver regeneration after hepatectomy. Am. J. Physiol. Gastrointest Liver Physiol. 298, G74-G80 (2009).
151. Xue, J., Nguyen, D. T., Habtezion, A. Aryl hydrocarbon receptor regulates pancreatic IL-22 production and protects mice from acute pancreatitis. Gastroenterology 143, 1670-1680 (2012).
152. Feng, D. et al. Interleukin-22 ameliorates cerulein-induced pancreatitis in mice by inhibiting the autophagic pathway. Int. J. Biol. Sci. 8, 249-257 (2012).
153. Kulkarni, O. P. et al. Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. J. Am. Soc. Nephrol. 25, 978-989 (2014).
154. Xu, M. J. et al. IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium. J. Am. Soc. Nephrol. 25, 967-977 (2014).
155. Dudakov, J. A. et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science 336, 91-95 (2012).
156. Hsu, Y. H. et al. Interleukin-19 mediates tissue damage in murine ischemic acute kidney injury. PLoS ONE 8, e56028 (2013).
157. Chiu, Y. S., Wei, C. C., Lin, Y. J., Hsu, Y. H., Chang, M. S. IL-20 and IL-20R1 antibodies protect against liver fibrosis. Hepatology 60, 1003-1014 (2014).
158. Hsu, Y. H. et al. Anti-IL-20 monoclonal antibody suppresses breast cancer progression and bone osteolysis in murine models. J. Immunol. 188, 1981-1991 (2012).
159. Baird, A. M., Gray, S. G., O'Byrne, K. J. IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF. Eur. J. Cancer 47, 1908-1918 (2011).
160. Hsu, Y. H., Wei, C. C., Shieh, D. B., Chan, C. H., Chang, M. S. Anti-IL-20 monoclonal antibody alleviates inflammation in oral cancer and suppresses tumor growth. Mol. Cancer Res. 10, 1430-1439 (2012).
161. Lee, S. J. et al. Interleukin-20 promotes migration of bladder cancer cells through extracellular signal-regulated kinase (ERK)-mediated MMP-9 protein expression leading to nuclear factor (NF-?B) activation by inducing the up-regulation of p21WAF1 protein expression. J. Biol. Chem. 288, 5539-5552 (2013).
162. Lee, S. J. et al. Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A. PLoS ONE 7, e40267 (2012).
163. Nagakawa, H. et al. Expression of interleukin-22 in murine carcinoma cells did not influence tumour growth in vivo but did improve survival of the inoculated hosts. Scand. J. Immunol. 60, 449-454 (2004).
164. Wen, Z. et al. High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma. Ann. Surg. Oncol. 21, 125-132 (2014).
165. Lim, C., Savan, R. The role of the IL-22/IL-22R1 axis in cancer. Cytokine Growth Factor Rev. 25, 257-271 (2014).
166. Emdad, L. et al. Historical perspective and recent insights into our understanding of the molecular and biochemical basis of the antitumor properties of mda-7/IL-24. Cancer Biol. Ther. 8, 391-400 (2009).
167. Whitaker, E. L., Filippov, V. A., Duerksen-Hughes, P. J. Interleukin 24: mechanisms and therapeutic potential of an anti-cancer gene. Cytokine Growth Factor Rev. 23, 323-331 (2012).
168. Kreis, S., Philippidou, D., Margue, C., Behrmann, I. IL-24: a classic cytokine and/or a potential cure for cancer? J. Cell. Mol. Med. 16, 2505-2510 (2008).
169. Kreis, S. et al. Recombinant interleukin-24 lacks apoptosis-inducing properties in melanoma cells. PLoS ONE 2, e1300 (2007).
170. Yu, H., Pardoll, D., Jove, R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Rev. Cancer 9, 798-809 (2009).
171. Musteanu, M. et al. Stat3 is a negative regulator of intestinal tumor progression in ApcMin mice. Gastroenterology 138, 1003-1011.e1-5 (2010).
172. You, W. et al. IL-26 promotes the proliferation and survival of human gastric cancer cells by regulating the balance of STAT1 and STAT3 activation. PLoS ONE 8, e63588 (2013).
173. Meira, L. B. et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J. Clin. Invest. 118, 2516-2525 (2008).
174. Kirchberger, S. et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J. Exp. Med. 210, 917-931 (2013).
175. Yang, L. et al. Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22. J. Hepatol. 53, 339-347 (2010)
176. Kanneganti, T. D., Dixit, V. D. Immunological complications of obesity. Nature Immunol. 13, 707-712 (2012).
177. Inoue, H. et al. Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nature Med. 10, 168-174 (2004).
178. Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231 (2010).
179. Wang, X. et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nature 514, 237-241 (2014).
180. Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695 (2005).
181. Prodanovich, S. et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch. Dermatol. 145, 700-703 (2009).
182. Ellison, S. et al. Attenuation of experimental atherosclerosis by interleukin-19. Arterioscler Thromb. Vasc. Biol. 33, 2316-2324 (2013).
183. Chen, W. Y., Cheng, B. C., Jiang, M. J., Hsieh, M. Y., Chang, M. S. IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice. Arteriosclerosis, Thromb. Vascular Biol. 26, 2090-2095 (2006).
184. Zenewicz, L. A. et al. IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. J. Immunol. 190, 5306-5312 (2013).
185. Gaboriau-Routhiau, V. et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689 (2009).
186. Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498 (2009).
187. Wu, H.-J. et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815-827 (2010).
188. Lee, Y. K., Menezes, J. S., Umesaki, Y., Mazmanian, S. K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4615-4622 (2011).
189. Qiu, J. et al. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 39, 386-399 (2013).
190. Upadhyay, V. et al. Lymphotoxin regulates commensal responses to enable diet-induced obesity. Nature Immunol. 13, 947-953 (2012).